Breakdown |
---|
Income Statement |
Total Revenue |
Gross Profit |
EBITDA |
Net Income |
Balance Sheet |
Total Assets |
Cash, Cash Equivalents and Short-Term Investments |
Total Debt |
Total Liabilities |
Stockholders Equity |
Cash Flow |
Free Cash Flow |
Operating Cash Flow |
Investing Cash Flow |
Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £705.46M | 8.62 | 20.95% | 2.96% | 6.52% | 59.56% | |
77 Outperform | £527.49M | 7.81 | 16.51% | 2.77% | 16.42% | 33.12% | |
66 Neutral | £54.35M | 4.87 | 10.87% | ― | 5.39% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
45 Neutral | £6.32M | ― | -30.89% | ― | -6.07% | 50.59% | |
44 Neutral | £323.23K | ― | -46.96% | ― | ― | ― |